Common Equity: The sum of all common equity items.
Actuate Therapeutics, Inc. (ACTU) had Common Equity of $-5.09M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.32M |
|
-- |
|
-- |
|
$6.37M |
|
$-6.37M |
|
$0.05M |
|
$-6.32M |
|
$-6.32M |
|
$-6.32M |
|
$-6.32M |
|
$-6.32M |
|
$-6.32M |
|
$-6.37M |
|
$-6.37M |
|
19.50M |
|
19.50M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$4.25M |
|
-- |
|
$0.23M |
|
$4.48M |
|
$9.15M |
|
-- |
|
$0.42M |
|
$9.57M |
|
|
Common Equity |
$-5.09M |
$-5.09M |
|
$-5.09M |
|
19.53M |
|
| Cash Flow Statement Financials | |
$-4.62M |
|
-- |
|
$-0.13M |
|
$8.64M |
|
$3.89M |
|
$-4.75M |
|
$1.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
124.16% |
|
124.16% |
|
-140.91% |
|
124.16% |
|
$-0.26 |
|
$-0.24 |
|
$-0.24 |
|